Rintatolimod: with IFN for melanoma, colorectal cancer, prostate cancerWith pembrolizumab and cisplatin for ovarian cancerWith IFN and neoadjuvant chemotherapy for breast cancer. This evidence concerns the gene IFNA1 and breast carcinoma.